vs
Alector, Inc.（ALEC）与Valaris Ltd（VAL）财务数据对比。点击上方公司名可切换其他公司
Alector, Inc.的季度营收约是Valaris Ltd的1.2倍（$6.2M vs $5.2M），Valaris Ltd同比增速更快（405.9% vs -88.5%），Valaris Ltd自由现金流更多（$-34.1M vs $-184.1M），过去两年Valaris Ltd的营收复合增速更高（29.5% vs -37.4%）
Alector是一家临床阶段生物制药企业，专注于神经退行性疾病的免疫疗法研发，管线覆盖阿尔茨海默病、额颞叶痴呆、帕金森病等未被满足的医疗需求，主要在美国运营，与全球药企合作推进候选药物的临床试验。
瓦拉瑞斯有限公司是全球领先的海上钻井承包商，总部位于美国得克萨斯州休斯敦，注册地为百慕大，是全球规模最大的海上钻井及油井钻井服务企业。截至2025年2月，公司共运营52座钻井平台，包含36座海上自升式钻井平台、11艘钻井船以及5座半潜式钻井平台。
ALEC vs VAL — 直观对比
营收规模更大
ALEC
是对方的1.2倍
$5.2M
营收增速更快
VAL
高出494.4%
-88.5%
自由现金流更多
VAL
多$150.0M
$-184.1M
两年增速更快
VAL
近两年复合增速
-37.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $6.2M | $5.2M |
| 净利润 | — | $717.5M |
| 毛利率 | — | -7850.0% |
| 营业利润率 | — | — |
| 净利率 | — | 13798.1% |
| 营收同比 | -88.5% | 405.9% |
| 净利润同比 | -1696.9% | 436.6% |
| 每股收益（稀释后） | — | $10.13 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ALECVAL
| Q4 25 | $6.2M | $5.2M | ||
| Q3 25 | $3.3M | $5.6M | ||
| Q2 25 | $7.9M | $700.0K | ||
| Q1 25 | $3.7M | — | ||
| Q4 24 | $54.2M | $-1.7M | ||
| Q3 24 | $15.3M | $3.9M | ||
| Q2 24 | $15.1M | $4.8M | ||
| Q1 24 | $15.9M | $2.6M |
净利润ALECVAL
| Q4 25 | — | $717.5M | ||
| Q3 25 | $-34.7M | $188.1M | ||
| Q2 25 | $-30.5M | $115.1M | ||
| Q1 25 | $-40.5M | — | ||
| Q4 24 | $-2.1M | $133.7M | ||
| Q3 24 | $-42.2M | $64.6M | ||
| Q2 24 | $-38.7M | $149.6M | ||
| Q1 24 | $-36.1M | $25.5M |
毛利率ALECVAL
| Q4 25 | — | -7850.0% | ||
| Q3 25 | — | -7142.9% | ||
| Q2 25 | — | -56428.6% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 24529.4% | ||
| Q3 24 | — | -11748.7% | ||
| Q2 24 | — | -9039.6% | ||
| Q1 24 | — | -17007.7% |
营业利润率ALECVAL
| Q4 25 | — | — | ||
| Q3 25 | -1153.6% | — | ||
| Q2 25 | -433.6% | — | ||
| Q1 25 | -1216.5% | — | ||
| Q4 24 | -13.4% | — | ||
| Q3 24 | -315.7% | — | ||
| Q2 24 | -302.4% | — | ||
| Q1 24 | -275.0% | — |
净利率ALECVAL
| Q4 25 | — | 13798.1% | ||
| Q3 25 | -1063.4% | 3358.9% | ||
| Q2 25 | -387.7% | 16442.9% | ||
| Q1 25 | -1101.6% | — | ||
| Q4 24 | -3.8% | -7864.7% | ||
| Q3 24 | -275.2% | 1656.4% | ||
| Q2 24 | -256.4% | 3116.7% | ||
| Q1 24 | -227.0% | 980.8% |
每股收益（稀释后）ALECVAL
| Q4 25 | — | $10.13 | ||
| Q3 25 | $-0.34 | $2.65 | ||
| Q2 25 | $-0.30 | $1.61 | ||
| Q1 25 | $-0.41 | — | ||
| Q4 24 | $-0.02 | $1.86 | ||
| Q3 24 | $-0.43 | $0.88 | ||
| Q2 24 | $-0.40 | $2.03 | ||
| Q1 24 | $-0.38 | $0.35 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $256.0M | $599.4M |
| 总债务越低越好 | $10.0M | — |
| 股东权益账面价值 | $30.6M | $3.2B |
| 总资产 | $293.2M | $5.3B |
| 负债/权益比越低杠杆越低 | 0.33× | — |
8季度趋势，按日历期对齐
现金及短期投资ALECVAL
| Q4 25 | $256.0M | $599.4M | ||
| Q3 25 | $291.1M | $662.7M | ||
| Q2 25 | $307.3M | $503.4M | ||
| Q1 25 | $354.6M | — | ||
| Q4 24 | $413.4M | $368.2M | ||
| Q3 24 | $457.2M | $379.3M | ||
| Q2 24 | $503.3M | $398.3M | ||
| Q1 24 | $562.1M | $494.1M |
总债务ALECVAL
| Q4 25 | $10.0M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $10.0M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益ALECVAL
| Q4 25 | $30.6M | $3.2B | ||
| Q3 25 | $57.7M | $2.4B | ||
| Q2 25 | $71.2M | $2.3B | ||
| Q1 25 | $94.6M | — | ||
| Q4 24 | $126.8M | $2.2B | ||
| Q3 24 | $118.9M | $2.1B | ||
| Q2 24 | $150.6M | $2.2B | ||
| Q1 24 | $178.9M | $2.0B |
总资产ALECVAL
| Q4 25 | $293.2M | $5.3B | ||
| Q3 25 | $335.3M | $4.6B | ||
| Q2 25 | $356.4M | $4.5B | ||
| Q1 25 | $408.3M | — | ||
| Q4 24 | $468.3M | $4.4B | ||
| Q3 24 | $516.0M | $4.3B | ||
| Q2 24 | $570.7M | $4.4B | ||
| Q1 24 | $635.5M | $4.4B |
负债/权益比ALECVAL
| Q4 25 | 0.33× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.08× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-184.0M | $72.2M |
| 自由现金流经营现金流 - 资本支出 | $-184.1M | $-34.1M |
| 自由现金流率自由现金流/营收 | -2951.3% | -655.8% |
| 资本支出强度资本支出/营收 | 0.7% | 2044.2% |
| 现金转化率经营现金流/净利润 | — | 0.10× |
| 过去12个月自由现金流最近4个季度 | $-326.5M | $159.9M |
8季度趋势，按日历期对齐
经营现金流ALECVAL
| Q4 25 | $-184.0M | $72.2M | ||
| Q3 25 | $-32.5M | $198.1M | ||
| Q2 25 | $-49.0M | $120.0M | ||
| Q1 25 | $-60.8M | — | ||
| Q4 24 | $-55.0M | $124.6M | ||
| Q3 24 | $-50.7M | $193.0M | ||
| Q2 24 | $-62.8M | $11.5M | ||
| Q1 24 | $-61.3M | $26.3M |
自由现金流ALECVAL
| Q4 25 | $-184.1M | $-34.1M | ||
| Q3 25 | $-32.5M | $128.3M | ||
| Q2 25 | $-49.1M | $52.8M | ||
| Q1 25 | $-60.8M | — | ||
| Q4 24 | $-55.2M | $12.9M | ||
| Q3 24 | $-50.9M | $111.1M | ||
| Q2 24 | $-63.1M | $-98.7M | ||
| Q1 24 | $-61.9M | $-125.0M |
自由现金流率ALECVAL
| Q4 25 | -2951.3% | -655.8% | ||
| Q3 25 | -997.6% | 2291.1% | ||
| Q2 25 | -623.0% | 7542.9% | ||
| Q1 25 | -1655.0% | — | ||
| Q4 24 | -101.8% | -758.8% | ||
| Q3 24 | -332.1% | 2848.7% | ||
| Q2 24 | -418.6% | -2056.3% | ||
| Q1 24 | -389.3% | -4807.7% |
资本支出强度ALECVAL
| Q4 25 | 0.7% | 2044.2% | ||
| Q3 25 | 0.3% | 1246.4% | ||
| Q2 25 | 0.1% | 9600.0% | ||
| Q1 25 | 0.5% | — | ||
| Q4 24 | 0.3% | -6570.6% | ||
| Q3 24 | 1.4% | 2100.0% | ||
| Q2 24 | 2.2% | 2295.8% | ||
| Q1 24 | 3.4% | 5819.2% |
现金转化率ALECVAL
| Q4 25 | — | 0.10× | ||
| Q3 25 | — | 1.05× | ||
| Q2 25 | — | 1.04× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.93× | ||
| Q3 24 | — | 2.99× | ||
| Q2 24 | — | 0.08× | ||
| Q1 24 | — | 1.03× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
